WHITE PAPER
The Case for Patient Diversity in Clinical Trials
Mar 01, 2024
  • Library
  • The Case for Patient Diversity in Clinical Trials

Get instant access

Download

Learn how a global pharmaceutical manufacturer used site engagement technology to exceed an FDA-recommended goal for patient diversity in a Hepatitis-C trial.

You may also be interested in

Blog

How Technology Is Accelerating Site Activation: Examples From Novartis And IQVIA

By: Rosemary Shirey
Blog

Practical Approaches To Faster Study Start-Ups: Q&A With Industry Leaders

By: Raphaëlle Gilg, Kerry Randall, Rodrigo Guimarães, Rosemary Shirey
Webinar

Practical Approaches to Faster Study Start-Ups: Making Progress in the Face of Industry Headwinds

Video

IQVIA Investigator Site Portal

Make more sites your BEST sites
Fact Sheet

Orchestrated Study Start-Up with the IQVIA Investigator Site Portal

Reduce cycle time, speed site activation, and keep sites engaged with robust workflows and compliant eTMF filings

Related solutions

Site Suite

Increase transparency, improve communications and reduce administrative burden for all clinical trial stakeholders.

Investigator Site Portal

Communication, collaboration and transparency between sites and sponsors mean trials start up and close out faster.

Contact Us